Insights from 2023 ESGO Annual Meeting


 

ESGO 2023 Insights: "Long-Term Follow Up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer"

74 views
November 24, 2023
0 Comments
Login to view comments. Click here to Login